Healthcare >> CEO Interviews >> January 10, 2005


DR. DAVID S. YOUNG is President and CSO of Arius Research Inc. He oversees general corporate strategy and directs the company's scientific program. He received his Doctor of Medicine degree in 1990 and Master of Science degree through the Surgical Scientist Program in 1996, both from the University of Toronto. He did his surgical training at the University of Toronto between 1991 and 1997, including his surgical internship at the Toronto General Hospital, residency in General Surgery at Mount Sinai Hospital, and within the division of Cardiovascular Surgery at St. Michael's Hospital in Toronto. While at the University of Toronto he received 15 awards and/or scholarships. He is a diplomate of the Medical Council of Canada and of the National Board of Medical Examiners of the United States of America and holds an Independent Practice Certificate from the College of Physicians and Surgeons of Ontario. He is an author of more than 40 papers, abstracts and patents. From 1997 to 2001, he was a clinical associate in the Division of Cardiovascular Surgery at Michael's Hospital in Toronto. He began his research career studying the role of the immune system in xenograft rejection in cardiac transplantation and has moved forward investigating its role in cancer. Prior to founding ARIUS in 1999, he was a co-founder of Apogen Inc., a transplantation company, Vertis BioSciences Inc., a biotechnology company, and Diversified Medical Innovations, Inc., a medical devices company. Profile
TWST: What's gone on over the past year at ARIUS that investors should

focus on?

Dr. Young: I think we should spend a minutes on the history of ARIUS and

then I'll bring us up to date. One of